Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B-cell response in seasonal allergic rhinitis patients.
Mösges R, Koch AF, Raskopf E, Singh J, Shah-Hosseini K, Astvatsatourov A, Hauswald B, Yarin Y, Corazza F, Haazen L, Pirotton S, Allekotte S, Zadoyan G, Legon T, Durham SR, Shamji MH.
Mösges R, et al. Among authors: allekotte s.
Allergy. 2018 Jun;73(6):1254-1262. doi: 10.1111/all.13392. Epub 2018 Feb 13.
Allergy. 2018.
PMID: 29322510
Free PMC article.